Weida Tong PhD U.S. FDA

Weida Tong PhD

Weida Tong PhD U.S. FDA Director, Division of Bioinformatics and Biostatistics, NCTR

Dr. Tong is the Director of Division of Bioinformatics and Biostatistics at NCTR/FDA. He is Senior Biomedical Research and Biomedical Product Assessment Service (SBRBPAS) Expert (formally Senior Biomedical Research Service) since 2011 at FDA. He has served Science Advisory Board for several multi-institutional projects in Europe and USA. He also holds adjunct appointment at several universities. He is the founder and board chairperson of international MAQC Society (2017-2020), President of MCBIOS Society (2019-2020), and Chair of SOT Board of Publication (2019-2020). He has published over 300 peer-reviewed papers from his roles in (1) Supervising and leading the FDA-led community wide MicroArray and SEquencing Quality Control (MAQC/SEQC) consortium to assess technical performance and practical utility of emerging genomic technologies with emphasis on regulatory application and precision medicine, (2) addressing the drug safety concerns related to drug-induced liver injury (DILI), (3) developing machine learning and AI for digital health and drug repositioning, and (4) conducting molecular modeling and QSARs on various toxicological endpoints such as carcinogenicity.